DICOT Share Price Performance
Recent DICOT News & Updates
No updates
Dicot Pharma AB Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.033
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
Dicot Pharma AB Competitors
About DICOT
- Founded
- 2015
- Employees
- 3
- CEO
- WebsiteView website
Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It is developing LIB-01 for the treatment of erectile dysfunction and premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden.
Swedish Market Performance
- 7 Days: -3.5%
- 3 Months: 1.1%
- 1 Year: -0.4%
- Year to Date: -1.5%
Over the last 7 days, the market has dropped 3.5%, driven by pullbacks in every sector, especially the Industrials sector. Although the market performance has been flat over the past year. As for the next few years, earnings are expected to grow by 17% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading